Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Equifax

Elaine Mendonca by Elaine Mendonca
February 9, 2024
in Breaking News
0
Finance_Commercial (2)
0
SHARES
62
VIEWS
Share on FacebookShare on Twitter

As of February 9, 2024, a total of 13 financial analysts have shared their ratings on Equifax (NYSE:EFX) in the last three months. Let’s take a look at their recent assessments and compare them to the previous months:

– Bullish: Out of the 13 analysts, 7 have provided a bullish rating for Equifax. In the last 30 days, 1 analyst rated it as bullish, while there were no bullish ratings one month ago. However, 4 analysts were bullish two months ago, and 2 analysts were bullish three months ago.

– Somewhat Bullish: 2 analysts have given a somewhat bullish rating for Equifax. There were no recent ratings in the last 30 days, but 2 analysts had a somewhat bullish view two months ago. There were no such ratings three months ago.

– Indifferent: 4 analysts have expressed an indifferent stance towards Equifax. None of them have provided a recent rating in the last 30 days. However, 1 analyst was indifferent one month ago, and both 1 analyst and 2 analysts were indifferent two months ago and three months ago, respectively.

– Somewhat Bearish and Bearish: There have been no analysts who rated Equifax as somewhat bearish or bearish in the past three months.

Looking at the average 12-month price target for Equifax, it stands at $267.0. The highest estimate is $315.00, while the lowest estimate is $195.00. This reflects a significant 36.45% increase from the previous average price target of $195.67. In the current month, Equifax has received 15 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings, with an average analyst price target of $275.07.

Recent analyst actions have included a range of ratings and adjustments to price targets. For instance, Kyle Peterson from Needham has maintained a Buy rating for Equifax with a price target of $305.00. On the other hand, Simon Clinch from Redburn Atlantic has announced a Neutral rating with a price target of $272.00.

To summarize, the majority of analysts have provided positive ratings for Equifax, suggesting an upside potential for the stock. However, it is crucial to consider a diverse range of perspectives and conduct thorough research before making any investment decisions.

Equifax Inc. (EFX) Demonstrates Strong Performance in Stock Market, Attracting Investor Attention

On February 9, 2024, Equifax Inc. (EFX) showcased a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, EFX exhibited positive price momentum and caught the attention of investors.

The price of EFX shares witnessed a significant increase of $10.20 since the market last closed, representing a rise of 4.22%. Closing at $252.06, the stock demonstrated its strength and potential for further growth.

Even after the market closed, EFX continued its upward trajectory in after-hours trading. The stock rose an additional $1.93, indicating sustained investor interest and confidence in the company’s future prospects.

EFX’s strong performance can be attributed to several factors. Firstly, trading near the top of its 52-week range indicates that the stock has been consistently performing well over the past year. This suggests that investors have been bullish on EFX and have continued to support its growth.

Moreover, EFX’s ability to stay above its 200-day simple moving average is another positive sign. The 200-day moving average is a widely followed technical indicator that helps identify the overall trend of a stock. When a stock remains above its 200-day moving average, it suggests that the stock is in an uptrend and has the potential to continue rising.

The rise in EFX’s stock price on February 9, 2024, can be seen as a reflection of the company’s strong fundamentals and positive market sentiment. Equifax Inc. is a leading global data, analytics, and technology company that provides information solutions to businesses and consumers. With its extensive data resources and advanced analytics capabilities, EFX has positioned itself as a key player in the industry.

Investors are likely optimistic about EFX’s future prospects, considering the company’s ability to generate revenue and deliver value to its customers. As businesses increasingly rely on data-driven insights to make informed decisions, Equifax’s services become even more valuable.

While past performance is not indicative of future results, EFX’s strong showing on February 9, 2024, suggests that the stock may continue to attract investor attention and potentially deliver further gains. However, it is important for investors to conduct thorough research and consider various factors before making investment decisions.

Equifax Inc. Financial Performance: Steady Revenue but Decline in Net Income and EPS

On February 9, 2024, Equifax Inc. (EFX) showcased its financial performance for the past year and the fourth quarter. Total revenue has remained steady for Equifax over the past year, amounting to $5.26 billion. However, the net income for EFX tells a different story. Over the course of the past year, Equifax recorded a net income of $545.30 million, a decrease of 21.67% compared to the previous year. The earnings per share (EPS) for Equifax also experienced a decline, with an EPS of $4.40 over the past year, a decrease of 22.07% compared to the previous year. These figures indicate that while Equifax managed to maintain a stable total revenue, its net income and earnings per share experienced a decline. Investors and stakeholders in Equifax might be concerned about the decline in net income and EPS. External factors such as changes in market conditions, increased competition, or regulatory challenges could have impacted Equifax’s ability to generate higher profits. It is also important to assess the company’s internal strategies and initiatives to address these challenges and improve its financial standing. Investors should consider these figures in conjunction with other relevant information to gain a holistic view of Equifax’s financial standing and make informed investment choices.

Tags: EFX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Humacytes Revolutionary Human Acellular Vessel Receives Priority Review from FDA

AMETEK Inc Announces Impressive Increase in Quarterly Dividend

Technology Cloud computing Trading online

AgEagle Aerial Systems Implements Reverse Stock Split to Maintain NYSE American Listing

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com